Your browser doesn't support javascript.
loading
Allogeneic transplantation with myeloablative FluBu4 conditioning improves survival compared to reduced intensity FluBu2 conditioning for acute myeloid leukemia in remission.
Magenau, John M; Braun, Thomas; Reddy, Pavan; Parkin, Brian; Pawarode, Attaphol; Mineishi, Shin; Choi, Sung; Levine, John; Li, Yumeng; Yanik, Gregory; Kitko, Carrie; Churay, Tracey; Frame, David; Riwes, Mary Mansour; Harris, Andrew; Bixby, Dale; Couriel, Daniel R; Goldstein, Steven C.
Affiliation
  • Magenau JM; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA, johnmage@med.umich.edu.
Ann Hematol ; 94(6): 1033-41, 2015 Jun.
Article in En | MEDLINE | ID: mdl-25784222
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vidarabine / Busulfan / Leukemia, Myeloid, Acute / Hematopoietic Stem Cell Transplantation / Transplantation Conditioning / Myeloablative Agonists Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Ann Hematol Journal subject: HEMATOLOGIA Year: 2015 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vidarabine / Busulfan / Leukemia, Myeloid, Acute / Hematopoietic Stem Cell Transplantation / Transplantation Conditioning / Myeloablative Agonists Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Ann Hematol Journal subject: HEMATOLOGIA Year: 2015 Document type: Article Country of publication: